Arthritis medicines and cardiovascular events--"house of coxibs"

JAMA. 2005 Jan 19;293(3):366-8. doi: 10.1001/jama.293.3.366. Epub 2004 Dec 28.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adenoma / prevention & control
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis / drug therapy
  • Cardiovascular Diseases / chemically induced*
  • Celecoxib
  • Cyclooxygenase Inhibitors / adverse effects*
  • Cyclooxygenase Inhibitors / therapeutic use
  • Drug Approval
  • Humans
  • Isoxazoles / adverse effects
  • Pyrazoles / adverse effects*
  • Pyrazoles / therapeutic use
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Isoxazoles
  • Pyrazoles
  • Sulfonamides
  • valdecoxib
  • Celecoxib